Show simple item record

dc.contributor.authorSetyawan, Yuswanto
dc.date.accessioned2024-07-03T04:32:42Z
dc.date.available2024-07-03T04:32:42Z
dc.date.issued2024
dc.identifier.issn2746-5357
dc.identifier.urihttps://dspace.uc.ac.id/handle/123456789/7379
dc.description.abstractBronchial asthma is a lung disease characterized by reversible airway obstruction both spontaneously and with treatment, characterized by airways inflammation and hyperreactivity to various stimuli. Until now, the most effective treatment for asthma are corticosteroids and β-agonists, while the administration of prophylactic drugs is often less effective and often causes very disturbing side effects. Vitamin D is a group of fat-soluble secosteroids. Vitamin D has functions in modulating neuromuscular function, reducing inflammation and influencing the work of various genes that regulate cell proliferation, differentiation and apoptosis. Research shows that low levels of vitamin D are associated with increased allergy markers and asthma levels. Vitamin D is believed to play a role in asthma by inhibiting respiratory tract smooth muscle proliferation via hyperphosphorylation of the retinoblastoma protein and activation of checkpoint kinase 1 (Chk1). Vitamin D has recently been considered as a treatment for asthma.en_US
dc.publisherUniversitas Ciputraen_US
dc.subjectvitamin Den_US
dc.subjectbronchial asthmaen_US
dc.titleVITAMIN D PADA ASMA BRONKIALen_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record